Cardiovascular Health
About HDI's Products
News/Studies
Bibliography
International
Contact Us
Home

       

News
Current news, archives, research and investor news

  

Research Study Archives:

       

   

    

   
 

  
Hypertension Diagnostics Provides Additional HDI/PulseWave™
CR-2000 Profiling Systems to Pfizer, Inc. for Major Study
 December 5, 2001 –

Hypertension Diagnostics’ HDI/PulseWave™ CR-2000 Research Instrument Selected by Pfizer, Inc. for Major Study
October 25, 2000 – 

Hypertension Diagnostics’ HDI/PulseWave™ CR-2000 Research System Included in NIH/NHLBI 10-Year Multi-Ethnic Study of Atherosclerosis
October 10, 2000 –     

Hypertension Diagnostics’ HDI/PulseWave™
CR-2000 Research Instrument Included in Solvay Pharmaceuticals, Inc. Study
September 26, 2000 – 

Hypertension Diagnostics’ CR-2000 Research System Included in the Alteon Inc. ALT-711, A.G.E. ‘Crosslink Breaker’, Phase II, Clinical Pharmaceutical Trial
April 7, 2000 – 

Hypertension Diagnostics’ HDI/PulseWave™ CR-2000 Research Instrument Included in the AstraZeneca, LP "TROPHY" Study
September 30, 1999 – 

Hypertension Diagnostics’ HDI/PulseWave™ CR-2000 is Selected by Parke-Davis Research Division for Inclusion in New Drug Trial
August 23, 1999 – 

   
       

Back to Top

 

   
 

Copyright © 2007 Hypertension Diagnostics, Inc
To learn more about HDI, email infoteam@hdii.com 
Last revised Sunday April 22, 2007